comparemela.com

Latest Breaking News On - Reiterated rating - Page 1 : comparemela.com

Compass Group (LON:CPG) Receives Buy Rating from Shore Capital

Shore Capital reaffirmed their buy rating on shares of Compass Group (LON:CPG – Free Report) in a research report sent to investors on Wednesday morning, MarketBeat reports. Several other brokerages have also recently issued reports on CPG. JPMorgan Chase & Co. restated an overweight rating and issued a GBX 2,600 ($32.66) target price on shares […]

Greggs (GRG) House Stock Rating Reiterated at Shore Capital

Shore Capital reaffirmed their house stock rating on shares of Greggs (LON:GRG – Free Report) in a research note released on Tuesday, Marketbeat Ratings reports. Other analysts also recently issued research reports about the stock. Berenberg Bank decreased their price objective on shares of Greggs from GBX 3,550 ($44.59) to GBX 3,390 ($42.58) and set […]

Aptitude Software Group s (APTD) Buy Rating Reaffirmed at Canaccord Genuity Group

Canaccord Genuity Group reissued their buy rating on shares of Aptitude Software Group (LON:APTD – Free Report) in a research note released on Tuesday, MarketBeat reports. The firm currently has a GBX 470 ($5.90) price objective on the stock. Aptitude Software Group Stock Up 2.8 % Shares of APTD opened at GBX 327 ($4.11) on […]

Carvana (NYSE:CVNA) Stock Rating Reaffirmed by JMP Securities

JMP Securities reaffirmed their market outperform rating on shares of Carvana (NYSE:CVNA – Free Report) in a research note released on Tuesday morning, Benzinga reports. The brokerage currently has a $135.00 target price on the stock. Several other analysts also recently weighed in on the company. William Blair reiterated an outperform rating on shares of […]

HC Wainwright Reiterates Neutral Rating for Aadi Bioscience (NASDAQ:AADI)

HC Wainwright reaffirmed their neutral rating on shares of Aadi Bioscience (NASDAQ:AADI – Free Report) in a research report released on Tuesday morning, Benzinga reports. HC Wainwright also issued estimates for Aadi Bioscience’s Q2 2024 earnings at ($0.66) EPS, Q4 2024 earnings at ($0.71) EPS, FY2024 earnings at ($2.73) EPS, Q1 2025 earnings at ($0.73) […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.